sglt2 inhibitors and glp 1 receptor agonists GLP-1 in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy | Drugs Use of GLP-1 Receptor Agonists
Description
Effect of tirzepatide on blood pressure and lipids: a meta-analysis of randomized controlled trials
PMC 3687347
In a rodent model, a novel GLP-1R/GIPR/GCGR triple agonist, SAR441255, has been shown to promote weight loss and the maintenance of healthy blood glucose levels and is superior to the GLP-1R/GCGR dual agonist (Saxena et al., 2023)
Groundbreaking Results from Clinical Trials The promise of retatrutide is not just theoreticalit is already supported by compelling clinical evidence
That is, until recently
The extracted information included: Study characteristics (authors, title, citation ID, abstract)
30031-7/asset/bedae7b4-4f80-4686-b4c7-9c3f908ac1bd/main.assets/gr1.jpg)
